Last updated 2026-07-26
- Raised $30M Series A, Dec 2021
- Raised $12M Seed Extension led by Misgav Technology Center, Dec 2011
- Raised $500k Seed round, Apr 2006
Total raised
$42.5M
Last: Undisclosed Round 2022-01
Stage
Series A
Founded
2018
Headcount
5
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Mirror Biologics is a clinical-stage biopharmaceutical company specializing in the development, manufacturing, and clinical translation of next-generation immunotherapy products where the active ingredients are living immune cells. The company's technology, including its patented immune cell AlloStim®, aims to reprogram the immune system to treat and prevent diseases like metastatic cancer and infectious diseases, and to address age-related immune decline. Mirror Biologics was founded in Jerusalem and operates a GMP aseptic manufacturing subsidiary in Jerusalem, Israel, with R&D and bioengineering labs in Tampa, Florida.
Funding history · 3 rounds · $42.5M total
2021-12
A Round
$30.0M
2011-12
Seed Extension
$12.0M
★ Misgav Technology Center
2006-04
Seed
$500K
Headcount over time
From 19 (2018-12) to 10 (2026-03) · -9 (-47%) · 22 points · source: Finder history + radar grounding
Q&A
- What is Mirror Biologics' primary focus?
- Mirror Biologics is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapy products using living immune cells to treat metastatic cancer and reverse age-related immune decline.
- When was Mirror Biologics founded?
- Mirror Biologics was founded in November 2018.
- What is the total amount of funding Mirror Biologics has raised to date?
- Mirror Biologics has raised a total of $42,500,000 in funding.
- Which investor led Mirror Biologics' Series A round in December 2021?
- Bradbury Asset Management (Hong Kong) led Mirror Biologics' Series A round in December 2021.
- How many employees does Mirror Biologics currently have?
- Mirror Biologics currently has 1-10 employees.
- What is Mirror Biologics' patented immune cell technology called?
- Mirror Biologics' patented immune cell technology is called AlloStim®.
- Where are Mirror Biologics' main operations located?
- Mirror Biologics was founded in Jerusalem, Israel, and operates a GMP aseptic manufacturing subsidiary there, with R&D and bioengineering labs in Tampa, Florida, USA.
Team · 1
Michael Har-Noy
Founder · Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
biotechnologycancerinfectious-diseasecell-therapyoncologyimmunotherapybiopharmaceuticalimmunologystem-cellspatientspharma-companiesvaccines
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | mirrorbio.com/ |
|---|---|
| linkedin.com/company/13180493 |
Identifiers & details
| Legal name | Mirror Biologics, Inc. |
|---|---|
| Former names | Immunovative Therapies |
| Founded | 2018-11 |
| Employees (exact) | 5 |
| Offices | Tampa; Malaysia; Bangkok |
Radar intelligence
Patents
| EPO | 13 |
|---|
Web history (Wayback)
| Domain | mirrorbio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 6 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513529792 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2004-03-30 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | אגודת ספורט הפועל 1 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |